SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas

• Type: Article in International Scientific Journal
• Date: 2005

Authors

Modena, P (Author) Other; Lualdi, E (Author) Other; Facchinetti, F (Author) Other; Galli, L (Author) Other; Manuel R Teixeira (Author) ICBAS; Pilotti, S (Author) Other; Sozzi, G (Author) Other

Journal

The Journal is awaiting validation by the Administrative Services.

Title: CANCER RESEARCH

Vol. 65

Pages: 4012-4019

ISSN: 0008-5472

Indexing

ISI Web of Knowledge - 232 Citations

Scopus - 256 Citations

Other information

Authenticus ID: P-000-3AQ

DOI: 10.1158/0008-5472.can-04-3050

Abstract (EN): Epithelioid sarcoma is a rare soft tissue neoplasm of uncertain lineage that usually arises in the distal extremities of adults, presents a high rate of recurrences and metastases and frequently poses diagnostic dilemmas. The recently reported large-cell "proximal-type" variant is characterized by increased aggressiveness, deep location, preferential occurrence in proximal/axial regions of older patients, and rhabdoid features. Previous cytogenetic studies indicated that the most frequent alterations associated with this tumor entity affect chromosome 22. In this study, combined spectral karyotyping, fluorescence in situ hybridization, and array-based comparative genomic hybridization analyses of two proximal-type cases harboring a rearrangement involving 10q26 and 22q11 revealed that the 22q11 breakpoints were located in a 150-kb region containing the SMARCB1/INI1 gene, and that homozygous deletion of the gene was present in the tumor tissue. The SMARCB1/INI1 gene encodes for an invariant subunit of SWI/SNF chromatin remodeling complex and has been previously reported to act as a tumor suppressor gene frequently inactivated in infantile malignant rhabdoid tumors. We analyzed SMARCB1/INI1 gene status in nine additional epithelioid sarcoma cases (four proximal types and five conventional types) and altogether we identified deletions of SMARCB1/INI1 gene in 5 of 11 cases, all proximal types. We confirmed and further extended the number of cases with SMARCB1/INI1 inactivation to 6 of 11 cases, by real-time quantitative PCR analysis of mRNA expression and by SMARCB1/INI1 immunohistochemistry. Overall, these results point to SMARCB1/INI1 gene involvement in the genesis and/or progression of epithelioid sarcomas. Analysis of larger series of epithelioid sarcomas will be necessary to highlight putative clinically relevant features related to SMARCB1/INI1 inactivation.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 8